Skip to content
Yüksel Ürün· @DrYukselUrun · X·· 23 hours agoScore90

VOLGA

Body

VOLGA: OS benefit without adjuvant EV.

Do we really need EV after surgery? An important question for future trials.

Proud to have contributed to this study.

@myESMO @OncoAlert @OpenMedicineHQ #ESMO26 @tompowles1 @Uromigos @urologysummit

357 views · 12 likes · 6 reposts · 0 replies

Conference abstracts
LBA2matched by Presidential Symposium I

Perioperative durvalumab with or without tremelimumab plus neoadjuvant enfortumab vedotin in muscle-invasive bladder cancer: Results from the phase 3 VOLGA trial

https://esmocongress.esmo.org

Source: Yüksel Ürün · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org